Aerska launches with €17.8M seed round to tackle Alzheimer’s and Parkinson’s
Dublin-based biotech startup Aerska has officially launched with a €17.8M ($21M) seed round to develop next-generation RNAi medicines targeting neurological diseases.

The best Articles in our Network